$168.46 +2.49 (%) Amgen Inc - NASDAQ

Apr. 21, 2015 | 04:00 PM

Partner Headlines

  1. Amgen, Illumina Crush Views

    IBD | Apr. 21, 2015 | 18:51PM EST
  2. Amgen, Illumina Earnings Hot, Intuitive Surgical Not

    IBD | Apr. 21, 2015 | 18:00PM EST
  3. Amgen Tops Q1 Expectations, Shares Gain

    Benzinga | Apr. 21, 2015 | 17:12PM EST
  4. Strategist: Amgen To Move 3% On Q1 Earnings News

    Benzinga | Apr. 21, 2015 | 15:13PM EST
  5. What The Street...And The Crowd Are Watching At Amgen Before Earnings

    Benzinga | Apr. 21, 2015 | 14:04PM EST
  6. Amgen Inc.'s First Quarter Earnings Preview - What Could Be In Store?

    GuruFocus | Apr. 20, 2015 | 13:41PM EST
  7. 5 Biotech Earnings Under The Microscope This Week

    Benzinga | Apr. 20, 2015 | 11:18AM EST
  8. Amgen's First Drug For Cardiovascular Disease Gets The Green Light

    GuruFocus | Apr. 17, 2015 | 22:41PM EST
  9. Why Amgen Might Start To Turn Around

    Benzinga | Apr. 17, 2015 | 12:51PM EST
  10. Amgen Has A Big Launch Coming Up

    Benzinga | Apr. 16, 2015 | 16:04PM EST
  11. AMGEN

    IBD | Apr. 15, 2015 | 18:37PM EST
  12. AbbVie Upgraded On $7.8 Billion Imbruvica Potential

    IBD | Apr. 13, 2015 | 11:19AM EST
  13. Short Sellers Come Back To Biotech Stocks

    Benzinga | Feb. 26, 2015 | 13:25PM EST
  14. Making Money With Charles Payne: 02/25/15

    FoxBusiness | Feb. 25, 2015 | 18:00PM EST
  15. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga | Feb. 23, 2015 | 07:34AM EST
  16. A Look At Dan Loeb's Diversified 13F

    Benzinga | Feb. 18, 2015 | 18:04PM EST
  17. Simons-Founded Renaissance Technologies Buys Apple, Closes Facebook, Trims McDonald's In Q4

    Benzinga | Feb. 13, 2015 | 14:19PM EST
  18. Short Sellers Retreat From Biotech Stocks

    Benzinga | Feb. 12, 2015 | 08:23AM EST
  19. FDA Advisory Committee To Review Amgen's Talimogene Laherparepvec

    Benzinga | Feb. 11, 2015 | 16:23PM EST
  20. Dan Loeb Offers Mea Culpa For 'Mediocre' Returns

    Benzinga | Feb. 10, 2015 | 12:37PM EST
  21. Dan Loeb Fourth Quarter Investor Letter

    GuruFocus | Feb. 10, 2015 | 10:55AM EST
  22. Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea

    IBD | Feb. 10, 2015 | 10:30AM EST
  23. Generic-Drug Makers Soar, And It's Easy To See Why

    IBD | Feb. 5, 2015 | 17:33PM EST
  24. Pfizer Buying Hospira To Inject Growth Into Generics

    IBD | Feb. 5, 2015 | 17:27PM EST
  25. Nuveen's Bob Doll Runs Several Top Funds

    IBD | Feb. 3, 2015 | 18:22PM EST
  26. Biotech Stocks Down Despite Strong Amgen Quarter

    IBD | Jan. 28, 2015 | 15:35PM EST
  27. Credit Suisse Sees Solid Q4 For Amgen

    Benzinga | Jan. 28, 2015 | 09:14AM EST
  28. Amgen Q4 earnings top views

    IBD | Jan. 27, 2015 | 18:37PM EST
  29. Drug Firms Report Good Q4, But Outlook Cloudy

    IBD | Jan. 27, 2015 | 18:10PM EST
  30. Making Money With Charles Payne: 01/27/15

    FoxBusiness | Jan. 27, 2015 | 18:00PM EST
  31. Amgen Beats Q4 Expectations

    Benzinga | Jan. 27, 2015 | 17:20PM EST
  32. Stocks Weaken Late; Apple Jumps After Hours

    IBD | Jan. 27, 2015 | 17:12PM EST
  33. Earnings Scheduled For January 27, 2015

    Benzinga | Jan. 27, 2015 | 04:34AM EST
  34. 5 Big Biotech Earnings Releases To Watch This Week

    Benzinga | Jan. 26, 2015 | 14:34PM EST
  35. Can CAR-T Therapy Live Up To The Biotech IPO Hype?

    IBD | Jan. 26, 2015 | 08:02AM EST
  36. New Guru Jana Partners' Newest Stock Buys

    GuruFocus | Jan. 22, 2015 | 21:05PM EST
  37. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD | Jan. 13, 2015 | 19:06PM EST
  38. Cholesterol Drug Costs Eyed

    IBD | Jan. 13, 2015 | 18:51PM EST
  39. Amgen's Decline May Be Linked To Comments Of Express Script's CEO

    Benzinga | Jan. 13, 2015 | 13:18PM EST
  40. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  41. Regeneron rises on drug data

    IBD | Jan. 9, 2015 | 18:42PM EST
  42. Crude Awakening As Energy Squeezes Overall Q4 Profit

    IBD | Jan. 9, 2015 | 17:58PM EST
  43. Regeneron Jumps On Favorable Cholesterol Drug Report

    IBD | Jan. 9, 2015 | 15:42PM EST
  44. Drugs May Be Blockbusters

    IBD | Jan. 8, 2015 | 18:54PM EST
  45. Weekly Review Shows Five Industries Gain In December

    IBD | Jan. 8, 2015 | 18:06PM EST
  46. 5 Potential Blockbuster Drugs Set To Launch In 2015

    IBD | Jan. 8, 2015 | 08:02AM EST
  47. Pharmaceutical Companies Amgen and Kite Partner for Cancer Therapy

    GuruFocus | Jan. 7, 2015 | 13:18PM EST
  48. Kite Pharma Gets Stock Price Increase Post Amgen Deal

    IBD | Jan. 6, 2015 | 15:07PM EST
  49. UPDATE: Barclays Initiates Coverage On Amgen

    Benzinga | Jan. 6, 2015 | 12:07PM EST
  50. Amgen, Kite Reach Cell Deal

    IBD | Jan. 5, 2015 | 18:44PM EST
Trading Center